Extreme Investor Network

Amgen’s Weight Loss Drug MariTide Initiates Two Phase 3 Trials

March 6, 2025

Amgen weight loss drug MariTide starts two phase three trials

Amgen Makes Strides in Obesity Treatment: The Launch of MariTide Trials In the ever-evolving landscape of the pharmaceutical industry, Amgen has taken a significant leap forward in the battle against obesity with its new experimental … Read more

Amgen’s small cell lung cancer treatment receives FDA approval

May 16, 2024

FDA approves Amgen small cell lung cancer treatment

Amgen’s Breakthrough Lung Cancer Treatment: A New Hope for Patients At Extreme Investor Network, we are excited to bring you the latest news in the world of business, including the recent approval of Amgen’s groundbreaking … Read more